Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric S Christenson

Showing results (21-30 of 43) with videos related to

Pageof 5
Sort By:
Clinical Chemistry|June 16, 2017
Single-Nucleotide Polymorphism Leading to False Allelic Fraction by Droplet Digital PCREric S Christenson, W Brian Dalton, David Chu, et al.
Biorxiv : the Preprint Server for Biology|September 2, 2025
Oncolytic peptide NF27 effectively inhibits tumor growth and eradicates tumors in multiple cancer typesNatsuki Furukawa, Alex R Chao, Wendy Yang, et al.
Molecular Pharmacology|April 2, 2021
Inhibition of Human Uracil DNA Glycosylase Sensitizes a Large Fraction of Colorectal Cancer Cells to 5-Fluorodeoxyuridine and Raltitrexed but Not FluorouracilEric S Christenson, Anthony Gizzi, Junru Cui, et al.
Frontiers in Oncology|June 23, 2023
Colorectal cancer in patients of advanced age is associated with increased incidence of <i>BRAF</i> p.V600E mutation and mismatch repair deficiencyEric S Christenson, Hua-Ling Tsai, Dung T Le, et al.
Cancer Research Communications|March 27, 2023
Cell-free DNA Predicts Prolonged Response to Multi-agent Chemotherapy in Pancreatic Ductal AdenocarcinomaEric S Christenson, Su Jin Lim, Jennifer Durham, et al.
American Journal of Clinical Oncology|June 14, 2022
Nonoperative Management Following Complete Response in Rectal Cancer After Short-course Radiation Therapy and Consolidation Chemotherapy: Clinical Outcomes and Quality of Life MeasuresAbhinav V Reddy, Bashar Safar, Angela Y Jia, et al.
JCI Insight|July 15, 2025
Ablating UNG activity in a mouse model inhibits colorectal cancer growth by increasing tumor immunogenicityEric S Christenson, Brandon E Smith, Thanh J Nguyen, et al.
Current Oncology (Toronto, Ont.)|January 20, 2023
Solid Organ Transplantation Is Associated with an Increased Rate of Mismatch Repair Deficiency and PIK3CA Mutations in Colorectal CancerEric S Christenson, Valerie Lee, Hao Wang, et al.
Practical Laboratory Medicine|August 25, 2018
Biotinylated amplicon sequencing: A method for preserving DNA samples of limited quantityKaren Cravero, Arielle Medford, Aparna Pallavajjala, et al.
The American Surgeon|May 9, 2025
Sustained Organ Preservation in Patients With Rectal Cancer After Sequential Short-Course Radiation Therapy and ChemotherapyI-Chia Liu, Susan Gearhart, Chen Hu, et al.
Pageof 5

Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Clinical Chemistry|June 16, 2017
Single-Nucleotide Polymorphism Leading to False Allelic Fraction by Droplet Digital PCREric S Christenson, W Brian Dalton, David Chu, et al.
Biorxiv : the Preprint Server for Biology|September 2, 2025
Oncolytic peptide NF27 effectively inhibits tumor growth and eradicates tumors in multiple cancer typesNatsuki Furukawa, Alex R Chao, Wendy Yang, et al.
Molecular Pharmacology|April 2, 2021
Inhibition of Human Uracil DNA Glycosylase Sensitizes a Large Fraction of Colorectal Cancer Cells to 5-Fluorodeoxyuridine and Raltitrexed but Not FluorouracilEric S Christenson, Anthony Gizzi, Junru Cui, et al.
Frontiers in Oncology|June 23, 2023
Colorectal cancer in patients of advanced age is associated with increased incidence of <i>BRAF</i> p.V600E mutation and mismatch repair deficiencyEric S Christenson, Hua-Ling Tsai, Dung T Le, et al.
Cancer Research Communications|March 27, 2023
Cell-free DNA Predicts Prolonged Response to Multi-agent Chemotherapy in Pancreatic Ductal AdenocarcinomaEric S Christenson, Su Jin Lim, Jennifer Durham, et al.
American Journal of Clinical Oncology|June 14, 2022
Nonoperative Management Following Complete Response in Rectal Cancer After Short-course Radiation Therapy and Consolidation Chemotherapy: Clinical Outcomes and Quality of Life MeasuresAbhinav V Reddy, Bashar Safar, Angela Y Jia, et al.
JCI Insight|July 15, 2025
Ablating UNG activity in a mouse model inhibits colorectal cancer growth by increasing tumor immunogenicityEric S Christenson, Brandon E Smith, Thanh J Nguyen, et al.
Current Oncology (Toronto, Ont.)|January 20, 2023
Solid Organ Transplantation Is Associated with an Increased Rate of Mismatch Repair Deficiency and PIK3CA Mutations in Colorectal CancerEric S Christenson, Valerie Lee, Hao Wang, et al.
Practical Laboratory Medicine|August 25, 2018
Biotinylated amplicon sequencing: A method for preserving DNA samples of limited quantityKaren Cravero, Arielle Medford, Aparna Pallavajjala, et al.
The American Surgeon|May 9, 2025
Sustained Organ Preservation in Patients With Rectal Cancer After Sequential Short-Course Radiation Therapy and ChemotherapyI-Chia Liu, Susan Gearhart, Chen Hu, et al.
Pageof 5